Nurse Practitioner, Family · Council Bluffs, IA
NPI
1992105092
Since 2014
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1702 N 16th St
Council Bluffs, IA, 51501
Phone (712) 227-4441
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$938K
5,748 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kahla N Anderson prescribed most often to Medicare patients was Pantoprazole Sodium, with 296 prescriptions and refills. In total Kahla N Anderson wrote 5,748 Medicare prescriptions that cost $938K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Pantoprazole Sodium Generic | 296 | 296 | 40 | $24K |
| Levothyroxine Sodium Generic | 221 | 221 | 26 | $3,879 |
| Pravastatin Sodium Generic | 216 | 216 | 25 | $11K |
| Potassium Chloride Generic | 202 | 202 | 36 | $6,157 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 192 | 192 | 27 | $21K |
| Gabapentin Generic | 181 | 182 | 31 | $7,613 |
| Rosuvastatin Calcium Generic | 152 | 152 | 29 | $15K |
| Atenolol Generic | 127 | 127 | 19 | $2,516 |
| Furosemide Generic | 123 | 123 | 20 | $1,247 |
| Metoprolol Succinate Generic | 117 | 117 | 17 | $2,338 |
| Eliquis Apixaban | 101 | 101 | 15 | $52K |
| Gemtesa Vibegron | 97 | 97 | 16 | $45K |
| Amlodipine Besylate Generic | 87 | 87 | 13 | $2,645 |
| Torsemide Generic | 87 | 87 | 11 | $2,696 |
| Duloxetine Hcl Generic | 84 | 84 | Under 11 | $7,335 |
Brand drugs: 1,220 claims; generic drugs: 4,508 claims; opioid claims: 212.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kahla N Anderson were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.